Suppr超能文献

评价新合成的 2-(噻吩-2-基)-1H-吲哚衍生物作为抗癌剂通过细胞周期阻滞和下调 miR-25 对 HCT-116 细胞增殖的作用。

Evaluation of newly synthesized 2-(thiophen-2-yl)-1H-indole derivatives as anticancer agents against HCT-116 cell proliferation via cell cycle arrest and down regulation of miR-25.

机构信息

Organometallic and Organometalloid Chemistry Department, National Research Centre, Dokki, 12622, Cairo, Egypt.

Medical Biochemistry Department, Medicine and Clinical Studies Research Institute, National Research Centre, Dokki, 12622, Cairo, Egypt.

出版信息

Sci Rep. 2024 Aug 29;14(1):20045. doi: 10.1038/s41598-024-68815-8.

Abstract

In the present study, we prepared new sixteen different derivatives. The first series were prepared (methylene)bis(2-(thiophen-2-yl)-1H-indole) derivatives which have (indole and thiophene rings) by excellent yield from the reaction (2 mmol) 2-(thiophen-2-yl)-1H-indole and (1 mmol) from aldehyde. The second series were synthesized (2-(thiophen-2-yl)-1H-indol-3-yl) methyl) aniline derivatives at a relatively low yield from multicomponent reaction of three components 2-(thiophen-2-yl)-1H-indole, N-methylaniline and desired aldehydes. The anticancer effect of the newly synthesized derivatives was determined against different cancers, colon, lung, breast and skin. The counter screening was done against normal Epithelial cells (RPE-1). The effect on cell cycle and mechanisms underlying of the antitumor effect were also studied. All new compounds were initially tested at a single dose of 100 μg/ml against this panel of 5 human tumor cell lines indicated that the compounds under investigation exhibit selective cytotoxicity against HCT-116 cell line and compounds (4g, 4a, 4c) showed potent anticancer activity against HCT-116 cell line with the inhibitory concentration IC values were, 7.1±0.07, 10.5± 0.07 and 11.9± 0.05 μΜ/ml respectively. Also, the active derivatives caused cell cycle arrest at the S and G2/M phase with significant(p < 0.0001) increase in the expression levels of tumor suppressors miR-30C, and miR-107 and a tremendous decrease in oncogenic miR-25, IL-6 and C-Myc levels. It is to conclude that the anticancer activity could be through direct interaction with tumor cell DNA like S-phase-dependent chemotherapy drugs. Which can interact with DNA or block DNA synthesis such as doxorubicin, cisplatin, or 5-fluorouracil and which were highly effective in killing the cancer cells. This data ensures the efficiency of the 3 analogues on inducing cell cycle arrest and preventing cancer cell growth. The altered expressions explained the molecular mechanisms through which the newly synthesized analogues exert their anticancer action.

摘要

在本研究中,我们制备了 16 种不同的新衍生物。第一个系列是通过(2mmol)2-(噻吩-2-基)-1H-吲哚和(1mmol)醛的反应,以优异的产率制备的(亚甲基)双(2-(噻吩-2-基)-1H-吲哚)衍生物,具有(吲哚和噻吩环)。第二个系列是通过三组分反应(2-(噻吩-2-基)-1H-吲哚,N-甲基苯胺和所需的醛)合成(2-(噻吩-2-基)-1H-吲哚-3-基)甲基苯胺衍生物,产率相对较低。新合成衍生物的抗癌作用在不同的癌症(结肠、肺、乳腺和皮肤)中进行了测定。对照筛选是在正常上皮细胞(RPE-1)上进行的。还研究了对细胞周期的影响及其抗肿瘤作用的机制。所有新化合物最初都在单一剂量 100μg/ml 下对这一组 5 个人类肿瘤细胞系进行了测试,表明研究中的化合物对 HCT-116 细胞系具有选择性细胞毒性,化合物(4g、4a、4c)对 HCT-116 细胞系具有很强的抗癌活性,抑制浓度 IC 值分别为 7.1±0.07、10.5±0.07 和 11.9±0.05μM/ml。此外,活性衍生物导致细胞周期停滞在 S 和 G2/M 期,肿瘤抑制因子 miR-30C 和 miR-107 的表达水平显著增加(p<0.0001),致癌 miR-25、IL-6 和 C-Myc 水平显著降低。可以得出结论,抗癌活性可能是通过与肿瘤细胞 DNA 的直接相互作用,如 S 期依赖性化疗药物。可以与 DNA 相互作用或阻断 DNA 合成的药物,如阿霉素、顺铂或 5-氟尿嘧啶,这些药物对杀伤癌细胞非常有效。这些数据确保了这 3 种类似物在诱导细胞周期停滞和阻止癌细胞生长方面的效率。这些改变的表达解释了新合成类似物发挥其抗癌作用的分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdee/11362284/e097dd87a625/41598_2024_68815_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验